Industry & Hardware
Rewrite Therapeutics
United Stateswww.fiercebiotech.com/biotech/intellia-rewrites-pipeline-expansion-200m-acquisition-uc-berkeley-dna-writing-startup
Rewrite Therapeutics is an Industry & Hardware startup based in the United States, since acquired, 1 tracked investor.
Acquiredacquired
acquired
Stage
1
Investors
About Rewrite Therapeutics
Based in the United States, Rewrite Therapeutics is a startup. Rewrite Therapeutics has been acquired. Brouky classifies it under Industry & Hardware. Brouky records 1 investor associated with the company.
Rewrite Therapeutics is a UC Berkeley spinout developing CRISPR-guided DNA polymerization technology that enables genome editing without double-strand breaks, aiming to improve editing in non-dividing cell types.
Explore Rewrite Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.